[1] |
Kwok⁃Williams M, Perez Z, Squire R, et al. Radiotherapy for life⁃threatening mediastinal hemangioma with Kasabach⁃Merritt syndrome[J]. Pediatr Blood Cancer, 2007,49(5):739⁃744. doi: 10. 1002/pbc.20767.<br />
|
[2] |
Drolet BA, Trenor CC, Brandão LR, et al. Consensus⁃derived practice standards plan for complicated Kaposiform hemangioen⁃dothelioma[J]. J Pediatr, 2013,163(1):285⁃291. doi: 10.1016/j.jpeds.2013.03.080.<br />
|
[3] |
中华医学会整形外科分会血管瘤和脉管畸形学组. 血管瘤和脉管畸形诊断和治疗指南(2016版)[J]. 组织工程与重建外科杂志, 2016,12(2):63⁃93,97. doi: 10.3969/j.issn.1673⁃0364.2016. 02.001.<br />
|
[4] |
Kim T, Roh MR, Cho S, et al. Kasabach⁃merritt syndrome arising from tufted angioma successfully treated with systemic corti⁃costeroid[J]. Ann Dermatol, 2010,22(4):426⁃430. doi: 10.5021/ad.2010.22.4.426.<br />
|
[5] |
Peker E, Kirimi E, Tuncer O, et al. Brachial plexus paralysis due to giant cavernous hemangioma with Kasabach⁃Merritt syndrome: successful management with interferon alpha[J]. Platelets, 2009,20(8):603⁃605. doi: 10.3109/09537100903247790.<br />
|
[6] |
Boccara O, Fraitag S, Lasne D, et al. Kaposiform haemangioen⁃dothelioma⁃spectrum lesions with Kasabach⁃Merritt phenomenon: retrospective analysis and long⁃term outcome[J]. Acta Derm Venereol, 2016,96(1):77⁃81. doi: 10.2340/00015555⁃2185.<br />
|
[7] |
Fahrtash F, McCahon E, Arbuckle S. Successful treatment of kaposiform hemangioendothelioma and tufted angioma with vincristine[J]. J Pediatr Hematol Oncol, 2010,32(6):506⁃510. doi: 10.1097/MPH.0b013e3181e001a9.<br />
|
[8] |
Wang Z, Li K, Yao W, et al. Steroid⁃resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long⁃term follow⁃up[J]. Pediatr Blood Cancer, 2015,62(4):577⁃580. doi: 10.1002/pbc.25296.<br />
|
[9] |
李凯, 王作鹏, 姚伟, 等. 西罗莫司治疗难治性卡波西样血管内皮瘤初探[J]. 中华小儿外科杂志, 2014,35(12):886⁃889. doi: 10.3760/cma.j.issn.0253⁃3006.2014.12.002.<br />
|
[10] |
Thomson K, Pinnock R, Teague L, et al. Vincristine for the treatment of Kasabach⁃Merritt syndrome: recent New Zealand case experience[J]. N Z Med J, 2007,120(1249):U2418.<br />
|
[11] |
Traivaree C, Lumkul R, Torcharus K, et al. Outcome of Kasabach⁃Merritt phenomenon: the role of vincristine as monotherapy: report of a case[J]. J Med Assoc Thai, 2012,95 Suppl 5:S181⁃185.<br />
|
[12] |
Abass K, Saad H, Kherala M, et al. Successful treatment of kasabach⁃merritt syndrome with vincristine and surgery: a case report and review of literature[J]. Cases J, 2008,1(1):9. doi: 10.1186/1757⁃1626⁃1⁃9.<br />
|
[13] |
Hara K, Yoshida T, Kajiume T, et al. Successful treatment of Kasabach⁃Merritt syndrome with vincristine and diagnosis of the hemangioma using three⁃dimensional imaging[J]. Pediatr Hematol Oncol, 2009,26(5):375⁃380. doi: 10.1080/08880010902976643.<br />
|
[14] |
Drucker AM, Pope E, Mahant S, et al. Vincristine and corticosteroids as first⁃line treatment of Kasabach⁃Merritt syndrome in kaposiform hemangioendothelioma[J]. J Cutan Med Surg, 2009,13(3):155⁃159. doi: 10.2310/7750.2008.08006.<br />
|
[15] |
Wang P, Zhou W, Tao L, et al. Clinical analysis of Kasabach⁃Merritt syndrome in 17 neonates[J]. BMC Pediatr, 2014,14:146. doi: 10.1186/1471⁃2431⁃14⁃146.<br />
|
[16] |
Tan X, Chen M, Zhang J, et al. Treatment of corticosteroid⁃resistant vascular tumors associated with the Kasabach⁃Merritt phenomenon in infants: an approach with transcatheter arterial embolization plus vincristine therapy[J]. J Vasc Interv Radiol, 2016,27(4):569⁃575. doi: 10.1016/j.jvir.2015.12.012.<br />
|